Market Access Interest Group
Market access is central to the success of the healthcare industry and to patient outcomes. The term means something different to each of these stakeholder groups and equally to individual companies, health providers or patient organisations, according to their size and needs.
Principally market access involves preparing a positive environment which supports uptake of your product and demonstrating the ‘value’ of your product to the range of customers who influence uptake. Strategically, market access is about packaging data in the right way, for the right customer at the right time.
The PM Society Market Access Interest Group addresses the growing need for multiple stakeholders to understand their role in ‘market access’. Discussions are likely to be as diverse as the pharma/life sciences industries-patient dialogue, evidence requirements in the context of payer needs, the role of NHS liaison and the move from risk-sharing to value-based pricing. The Market Access group will also look to define, for the first time, the pharma and life sciences industries’ priority concerns relating to market access and, in time, to find practical solutions for overcoming barriers and establishing best practice.
We meet regularly to discuss common issues and focuses on:
- Learning and education
- Celebrating best practice
- Providing an opportunity to exchange ideas and network
Membership of the group is open to anyone with an interest in market access in its broadest sense, but the Society is particularly keen to hear from industry representatives.
Please email Helen or call 01403 264898 if you are interested in finding out more or to join the group.
More from the PM Society
Latest Market Access videos
Craig Bradley – PM Society Chairman, lead Market Access Interest Group and Brand Manager at Shire
Robert Whitemore – Market Access Interest Group member, Director, Roboleo & Co
Hassan Chaudhury – Market Access Interest Group member, Chief Commercial Officer, Health iQ
Latest Market Access articles
Patient Access to new medicines; the changing landscape
Introduction The market access landscape has changed substantially since the introduction of NICE (1999) and the PPRS (2009, updated...
Developing high value partnerships with the NHS
Hassan Chaudhury, is a member of the PM Society Market Access Group and is Chief Commercial Officer and Co-Founder,...
UK Market Access 2019 - Event Review
Speaker Bios and Slides Craig Bradley, Product & Business Lead Rare GI, Takeda Craig has worked for Takeda,...